Wrapping Up a Fantastic BIO-Europe Spring! ???? A huge thank you to everyone who took the time to meet with the MedPharm team—whether in pre-scheduled meetings or through spontaneous conversations at networking events. It was an incredible opportunity to connect, share insights, and explore ways we can support your development programs. As a leading end-to-end CDMO, MedPharm is committed to guiding our partners from early formulation development through clinical trials and commercial manufacturing. If you’re looking for expertise in topical and transdermal drug delivery, our team is here to help navigate the complexities of bringing your product to market. We’ll be following up soon and look forward to continuing the great discussions started at BIO! If we missed you at the event, let’s connect—we’d love to share how MedPharm can support your next innovation. Let's talk. [email protected] #BIOEuropeSpring #CDMO #Pharma #DrugDevelopment #TopicalExcellence #semisolidmanufacturing
关于我们
Bringing a groundbreaking topical or transepithelial therapy from concept to patient is no small feat. The journey is complex, filled with challenges like regulatory hurdles, market dynamics, and scientific unpredictability. That’s where MedPharm comes in. As the global gold standard in topical and transepithelial drug development and manufacturing, MedPharm is exclusively dedicated to transforming innovative ideas into successful therapies. With a specialized focus, we partner with pharmaceutical companies to streamline every stage of the drug development pipeline—from formulation and preclinical research to clinical trial material manufacturing and full-scale commercial production. Our expertise is grounded in decades of proven success. Through cutting-edge research methods, a deep understanding of regulatory landscapes, and an unwavering commitment to quality, MedPharm delivers tailored solutions that anticipate and adapt to the evolving needs of our clients. When you partner with MedPharm, you gain more than a CDMO—you gain a trusted ally committed to your success, ensuring your product reaches its full potential in the hands of patients worldwide. MedPharm: Advancing Topical and Transepithelial Therapies, Every Step of the Way.
- 网站
-
https://www.medpharm.com
MedPharm的外部链接
- 所属行业
- 制药业
- 规模
- 51-200 人
- 总部
- Durham,North Carolina
- 类型
- 私人持股
- 领域
- Topical and transdermal formulation development、GMP Clinical Trial Supply manufacture、Topical and transdermal drug delivery technology、Clinical Development Manufacturing Organization、IVPT/IVRT、Hormone Development、Hormone Manufacture、High Potency Capabilities、CDMO、CMO、Mucosal Drug Dev and Testing、Nasal cast models、Small Molecule、Patent Work、Semi-Solids、Dermal Delivery Services、Formulation topical North Caroline、Topical CDMO、Topical Nail Performance Testing、Ungual Delivery、Otic Product manufacturing、Otic Delivery formulation、Pharmaceutical Disease Activity Models和Pharmaceutical Performance Testing Services
地点
MedPharm员工
-
Amit Patel
Board Member. Former CEO. Investor.
-
Gary Gilliam
CEO & President, MedPharm Consulting, Inc, Philanthropist and Life Sciences and Devices Quality and Regulatory Consulting
-
Dave Haas
Information Technology Executive specializing in GXP manufacturing and lab services
-
Jon Lenn
Innovative Science Leader | Driving Research Excellence and Bridging Discovery to Market Success
动态
-
Reflecting on DCAT Week 2025, we want to extend a heartfelt thank you to everyone who made time to meet with us—whether it was a scheduled discussion, a quick hallway catch-up, or an unexpected conversation over coffee. ? These moments—big and small—are what make DCAT so valuable. We’re grateful for the opportunity to learn more about your goals, explore potential opportunities, and share how MedPharm can support your development and manufacturing needs, especially in topical, transdermal, and other complex drug delivery systems. Let's talk! [email protected] Our team left energized, with renewed focus and a deeper sense of connection to the incredible work happening across this industry. ? Here’s to continued collaboration and progress in 2025—and we hope to see you again next year at DCAT 2026. #DCATWeek #PharmaManufacturing #CDMO #TopicalExpertise #MedPharm #semisolidmanufacturing
-
-
DCAT Week is in full swing, but there’s still time to connect with the MedPharm team! Whether you're in early formulation or scaling up for commercial manufacturing, our experts are here to support your journey from molecule to market. Let’s discuss how MedPharm’s end-to-end topical and transdermal solutions can accelerate your success. Reach out to schedule a meeting before the week wraps up! [email protected] #DCATWeek #PharmaManufacturing #CDMO #TopicalExpertise #MedPharm
-
-
DCAT Week is almost here! MedPharm is gearing up for an exciting week at DCAT Week in NYC! As a leading CDMO specializing in topical and transdermal drug development and manufacturing, we’re looking forward to connecting with industry leaders, sharing insights, and exploring new collaborations. ?? Are you attending? Let’s meet to discuss how MedPharm’s expert-driven, end-to-end solutions can support your drug development journey from formulation through clinical and commercial manufacturing. ?? Secure time with our team in advance! Reach out at [email protected] #DCATWeek2025 #Pharma #CDMO #TopicalDrugDevelopment #Transdermal #MedPharm #Networking #BigApple
-
-
MedPharm at the Forefront of Dermatology Innovation – We are in Orlando! As the leading CDMO specializing in topical and transdermal drug development, we’re excited to connect with industry leaders, innovators, and partners to discuss the latest breakthroughs in dermatology. From early formulation to clinical and commercial manufacturing, MedPharm’s expertise ensures your product is developed with precision and success in mind. Let’s talk about how we can help bring your next dermatological innovation to market! Reach out to connect with our team at the conference. #DermatologyInnovation #AAD2025 #TopicalExperts #CDMO #PharmaInnovation #MedPharm #topicalsolutionsateverystage
-
MedPharm is committed to collaborative, transparent relationships, recognizing that successful partnerships extend beyond mere manufacturing. Our comprehensive technical expertise in topical and transdermal drug delivery and semi-solid formulations, providing robust process development, analytical capabilities, and scalable manufacturing. Adherence to stringent quality and compliance standards is paramount, with a proven track record of regulatory compliance and robust quality systems ensuring consistent product quality. Medpharm's flexibility and adaptability cater to the dynamic nature of drug development, offering project customization and capacity management to address evolving needs and fluctuating volumes. Strong project management practices, clear communication channels, and proactive updates ensure projects remain on track. Medpharm delivers exceptional value through transparent pricing and a comprehensive value proposition that emphasizes expertise, innovation, and reliability. As a reliable partner, Medpharm can seamlessly manage your drug development process from early stages to commercialization, maintaining high-quality standards and meeting specific project timelines and goals through a focus on collaboration and value delivery. Let's talk at DCAT! #CDMO #topical #DCAT #transdermal #MedPharm #commercialmanufacturing #earlystagedevelopment
-
-
Exciting Leadership News at MedPharm! We are thrilled to welcome Bill Humphries as MedPharm’s new Chief Executive Officer! With decades of leadership experience in the pharmaceutical industry and a proven track record of driving strategic growth, Bill is the perfect leader to guide MedPharm into its next phase of innovation and expansion. As a world-class CDMO specializing in topical and transdermal drug development, MedPharm is committed to delivering cutting-edge solutions from formulation development through commercial manufacturing. Bill’s expertise will be instrumental as we continue to elevate our services, expand our capabilities, and reinforce our position as the go-to partner for topical and transdermal product development. Welcome to the team, Bill! We’re excited for what’s ahead. ?? Read the full announcement here: https://lnkd.in/ezzMNKS8 #MedPharm #CDMO #Pharma #Leadership #TopicalDrugDevelopment #PharmaceuticalInnovation
-
If you are headed to San Francisco, we can't wait to meet you! #AID2025 #DermatologyInnovation #MedPharm #CDMO #JPM #DermSummit2025
-